<SEC-DOCUMENT>0001144204-11-019944.txt : 20110404
<SEC-HEADER>0001144204-11-019944.hdr.sgml : 20110404
<ACCEPTANCE-DATETIME>20110404142705
ACCESSION NUMBER:		0001144204-11-019944
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20110331
FILED AS OF DATE:		20110404
DATE AS OF CHANGE:		20110404

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Bronfeld Zeev
		CENTRAL INDEX KEY:			0001298522

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-50298
		FILM NUMBER:		11735054

	MAIL ADDRESS:	
		STREET 1:		6 URI STREET
		CITY:			TEL AVIV
		STATE:			L3
		ZIP:			64954

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ORAMED PHARMACEUTICALS INC.
		CENTRAL INDEX KEY:			0001176309
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				980376008
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			0831

	BUSINESS ADDRESS:	
		STREET 1:		2 ELZA STREET
		CITY:			JERUSALEM
		STATE:			L3
		ZIP:			93706
		BUSINESS PHONE:		011 972-54-7909058

	MAIL ADDRESS:	
		STREET 1:		2 ELZA STREET
		CITY:			JERUSALEM
		STATE:			L3
		ZIP:			93706

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Integrated Security Technologies, Inc.
		DATE OF NAME CHANGE:	20040614

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	IGUANA VENTURES LTD
		DATE OF NAME CHANGE:	20020625
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>v217494_ex.xml
<TEXT>
<XML>
<?xml version="1.0"?>
<ownershipDocument>

    <schemaVersion>X0303</schemaVersion>

    <documentType>4</documentType>

    <periodOfReport>2011-03-31</periodOfReport>

    <notSubjectToSection16>0</notSubjectToSection16>

    <issuer>
        <issuerCik>0001176309</issuerCik>
        <issuerName>ORAMED PHARMACEUTICALS INC.</issuerName>
        <issuerTradingSymbol>ORMP.OB</issuerTradingSymbol>
    </issuer>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001298522</rptOwnerCik>
            <rptOwnerName>Bronfeld Zeev</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>6 URI STREET</rptOwnerStreet1>
            <rptOwnerStreet2></rptOwnerStreet2>
            <rptOwnerCity>TEL AVIV</rptOwnerCity>
            <rptOwnerState>L3</rptOwnerState>
            <rptOwnerZipCode>64954</rptOwnerZipCode>
            <rptOwnerStateDescription>ISRAEL</rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>0</isDirector>
            <isOfficer>0</isOfficer>
            <isTenPercentOwner>1</isTenPercentOwner>
            <isOther>0</isOther>
        </reportingOwnerRelationship>
    </reportingOwner>

    <nonDerivativeTable>
        <nonDerivativeTransaction>
            <securityTitle>
                <value>Common Stock</value>
            </securityTitle>
            <transactionDate>
                <value>2011-03-31</value>
            </transactionDate>
            <transactionCoding>
                <transactionFormType>4</transactionFormType>
                <transactionCode>P</transactionCode>
                <equitySwapInvolved>0</equitySwapInvolved>
            </transactionCoding>
            <transactionAmounts>
                <transactionShares>
                    <value>781250</value>
                </transactionShares>
                <transactionPricePerShare>
                    <value>0.32</value>
                </transactionPricePerShare>
                <transactionAcquiredDisposedCode>
                    <value>A</value>
                </transactionAcquiredDisposedCode>
            </transactionAmounts>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>7213205</value>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>I</value>
                </directOrIndirectOwnership>
                <natureOfOwnership>
                    <value>Via DNA Biomedical Solutions Ltd.</value>
                </natureOfOwnership>
            </ownershipNature>
        </nonDerivativeTransaction>
    </nonDerivativeTable>

    <derivativeTable>
        <derivativeTransaction>
            <securityTitle>
                <value>Warrant</value>
            </securityTitle>
            <conversionOrExercisePrice>
                <value>0.50</value>
            </conversionOrExercisePrice>
            <transactionDate>
                <value>2011-03-31</value>
            </transactionDate>
            <transactionCoding>
                <transactionFormType>4</transactionFormType>
                <transactionCode>J</transactionCode>
                <equitySwapInvolved>0</equitySwapInvolved>
            </transactionCoding>
            <transactionAmounts>
                <transactionShares>
                    <value>273438</value>
                </transactionShares>
                <transactionPricePerShare>
                    <value>0</value>
                </transactionPricePerShare>
                <transactionAcquiredDisposedCode>
                    <value>A</value>
                </transactionAcquiredDisposedCode>
            </transactionAmounts>
            <exerciseDate>
                <value>2011-03-31</value>
            </exerciseDate>
            <expirationDate>
                <value>2016-03-31</value>
            </expirationDate>
            <underlyingSecurity>
                <underlyingSecurityTitle>
                    <value>Common Stock</value>
                </underlyingSecurityTitle>
                <underlyingSecurityShares>
                    <value>273438</value>
                </underlyingSecurityShares>
            </underlyingSecurity>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>273438</value>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>I</value>
                </directOrIndirectOwnership>
                <natureOfOwnership>
                    <value>Via D.N.A Biomedical Solutions Ltd.</value>
                </natureOfOwnership>
            </ownershipNature>
        </derivativeTransaction>
    </derivativeTable>

    <remarks>*This Form 4 reports the purchase from the Issuer of 781,250 shares of Common Stock (&quot;Shares&quot;) and warrants exercisable for
 273,438 Shares (the &quot;Warrants&quot;) by D.N.A Biomedical Solutions Ltd. (&quot;DNA&quot;), an Israeli public company, for a total purchase
 price of $250,000 in cash.  The Shares and Warrants were sold in units at a price per unit of $0.32, each unit consisting of
 one Share and a warrant to purchase 0.35 of a Share. The Warrants have an exercise price of $0.50 per Share.  The Reporting
 Person holds 23.3% of DNA's outstanding share capital.  The Reporting Person and Mr. Meni Mor are parties to a Voting
 Agreement relating to their shares of DNA, representing, in the aggregate, approximately 46.8% of DNA's outstanding share
 capital.  As a result of the Voting Agreement, the Reporting Person may be deemed a beneficial owner of, and toshare the
 power to vote and dispose, the Issuer securities held by DNA.  The Reporting Person disclaims beneficial ownership of any of
 the Issuer securities held by DNA.</remarks>

    <ownerSignature>
        <signatureName>/s/ Zeev Bronfeld</signatureName>
        <signatureDate>2011-04-04</signatureDate>
    </ownerSignature>
</ownershipDocument>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
